scPharmaceuticals, Inc. (SCPH) shares soared 8.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 35.3% gain over the past four weeks.The sudden price rise can be attributed to growing investor optimism related to the initial sales uptake of the company's marketed product, Furoscix (furosemide injection), which is indicated for the treatment of edema in adult patients with chronic he ...